Kymera Therapeutics Inc

KYMR

—

Build a strategy around KYMR

Kymera Therapeutics Inc AI Insights

Informational only. Not investment advice.

As of 2026-05-29

No AI insights available.

Professional, Scientific, and Technical Services → Professional, Scientific, and Technical Services

Metric	Value	YoY Growth	Industry Percentile
Market Cap	$6.02B		—
Enterprise Value	$5.96B		—
P/E Ratio	0.00		—
Total Revenue - TTM	$51.48M	-12.6%	—
Earnings Per Share (diluted) - TTM	$-3.58		—
Operating Margin - TTM	-690%	-217.7%	—
Net Margin - TTM	-612%	-202.9%	—
Free Cash Flow - TTM	$-244.0M		—
Return on Common Equity - TTM	-27.1%	+5.1%	—
Beta 5Y (Monthly)	unknown		—

No dividends

No stock splits

Filing Date	Report Date	Report Type	Filing Link
04/30/26	03/31/26	10-Q	0001193125-26-193967
02/26/26	12/31/25	10-K	0001193125-26-073395
11/04/25	09/30/25	10-Q	0001193125-25-263550
08/11/25	06/30/25	10-Q	0000950170-25-106229
05/09/25	03/31/25	10-Q	0000950170-25-067498
02/27/25	12/31/24	10-K	0000950170-25-028355
10/31/24	09/30/24	10-Q	0000950170-24-119249
08/07/24	06/30/24	10-Q	0000950170-24-092275
05/02/24	03/31/24	10-Q	0000950170-24-051567
02/22/24	12/31/23	10-K	0000950170-24-018414
11/02/23	09/30/23	10-Q	0000950170-23-057743
08/03/23	06/30/23	10-Q	0000950170-23-037581
05/04/23	03/31/23	10-Q	0000950170-23-017462
02/23/23	12/31/22	10-K	0000950170-23-003935
11/03/22	09/30/22	10-Q	0000950170-22-021543
08/09/22	06/30/22	10-Q	0000950170-22-015745
05/03/22	03/31/22	10-Q	0000950170-22-006947
02/24/22	12/31/21	10-K	0000950170-22-001860
11/10/21	09/30/21	10-Q	0000950170-21-003911
08/06/21	06/30/21	10-Q	0001564590-21-041902
05/06/21	03/31/21	10-Q	0001564590-21-024514
03/11/21	12/31/20	10-K	0001564590-21-012240
11/05/20	09/30/20	10-Q	0001564590-20-050872
08/21/20	06/30/20	424B4	0001193125-20-227121
05/06/21	03/31/20	10-Q	0001564590-21-024514
08/21/20	12/31/19	424B4	0001193125-20-227121
11/05/20	09/30/19	10-Q	0001564590-20-050872